NASDAQ: ETON - Eton Pharmaceuticals, Inc.

Lønnsomhet i seks måneder: +297.87%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Eton Pharmaceuticals, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and dehydrated alcohol injection to treat methanol poisoning.

flere detaljer
It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis; Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis; EPRONTIA, a liquid formulation of topiramate; ZONISADE, a liquid formulation of zonisamide for the treatment of partial seizures in patients with epilepsy; and Lamotrigine for Oral Suspension for the treatment of epilepsy. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2018-11-13
ISIN US29772L1089
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.etonpharma.com
Цена ао 3.81
Prisendring per dag: -3.83% (13.57)
Prisendring per uke: +3.82% (12.57)
Prisendring per måned: +2.43% (12.74)
Prisendring over 3 måneder: +125% (5.8)
Prisendring over seks måneder: +297.87% (3.28)
Prisendring per år: +197.95% (4.38)
Prisendring over 3 år: +216.75% (4.12)
Prisendring over 5 år: +108.13% (6.27)
Prisendring over 10 år: 0% (13.05)
Prisendring siden begynnelsen av året: +16.21% (11.23)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 3.78 4
P/BV 7.72 1
P/E 0 0
EV/EBITDA -355.93 0
Total: 3.63

Effektivitet

Navn Betydning Karakter
ROA, % -2.95 0
ROE, % -6.05 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -18.75 10
Total: 6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 3199.48 10
Lønnsomhet Ebitda, % -98.4 0
Lønnsomhet EPS, % -96.42 0
Total: 2
Flere detaljer

Institusjoner Volum Dele, %
Opaleye Management Inc. 2529887 9.85
Vanguard Group Inc 1027688 4
Westside Investment Management, Inc. 563110 2.19
Acuitas Investments LLC 492054 1.92
Paradigm Capital Management 300000 1.17
Blackrock Inc. 284241 1.11
Bridgeway Capital Management, Inc. 253362 0.99
Geode Capital Management, LLC 227256 0.88
Parkman Healthcare Partners LLC 199168 0.78
Ameriprise Financial, Inc. 161928 0.63

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.027 17.09 1.54048



Veileder Stillingstittel Betaling Fødselsår
Mr. Sean E. Brynjelsen President, CEO & Director 939.42k 1972 (53 år)
Mr. James R. Gruber CPA CFO, Treasurer & Secretary 554.44k 1972 (53 år)
Mr. David C. Krempa Chief Business Officer 547.86k 1989 (36 år)
Mr. Kevin Guthrie Executive VP of Commercial Operations N/A
Danka Radosavljevic Senior Vice President of Quality & Operations
Mr. Scott Grossenbach Vice President of Sales Operations

Adresse: United States, Deer Park. IL -, 21925 W. Field Parkway - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.etonpharma.com